There’s a better way to define obesity according to the commission
A panel of international scientists has proposed a revised definition of obesity that includes measuring waist circumference, using low-level X-rays to measure fat mass, and measuring a person’s level of adiposity. The definition, published in The Lancet Diabetes & Endocrinology, uses objective measures of illness instead of body mass index (BMI), which links a person’s weight to their height.
Drugmakers and pharmacy disagree over who gets to make the drugs
The US Food and Drug Administration (FDA) has issued a warning to a California pharmacy over allegations that it made a copy of Novo Nordisk’s obesity drug ‘Ozempic’. This comes after Novo Nordisk asked the FDA to add semaglutide, the key ingredient in Ozempic, to its list of drugs deemed too difficult to compound safely. Novo Nordisk said it has filed several lawsuits against compounders.